2015
DOI: 10.1016/j.jhsa.2015.06.024
|View full text |Cite
|
Sign up to set email alerts
|

Complications with the Use of BMP-2 in Scaphoid Nonunion Surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
16
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(17 citation statements)
references
References 0 publications
1
16
0
Order By: Relevance
“…RhBMP‐2 is the most potent osteoinductive agent available today; however, rhBMP‐2 has not fulfilled its clinical promise. First, when loaded on a collagen sponge, large doses of protein are needed to have an adequate biologic, and the use of supraphysiologic doses of rhBMP‐2 has led to questions about its clinical safety, and some clinical studies have demonstrated complications such as soft tissue edema, heterotopic ossification, and cyst formation associated with rhBMP‐2 use …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…RhBMP‐2 is the most potent osteoinductive agent available today; however, rhBMP‐2 has not fulfilled its clinical promise. First, when loaded on a collagen sponge, large doses of protein are needed to have an adequate biologic, and the use of supraphysiologic doses of rhBMP‐2 has led to questions about its clinical safety, and some clinical studies have demonstrated complications such as soft tissue edema, heterotopic ossification, and cyst formation associated with rhBMP‐2 use …”
Section: Discussionmentioning
confidence: 99%
“…First, when loaded on a collagen sponge, large doses of protein are needed to have an adequate biologic, 8,34 and the use of supraphysiologic doses of rhBMP-2 has led to questions about its clinical safety, and some clinical studies have demonstrated complications such as soft tissue edema, heterotopic ossification, and cyst formation associated with rhBMP-2 use. 35,36 Ex vivo regional gene therapy using a LV containing the cDNA for BMP-2 is a promising strategy that allows for sustained release of BMP-2 over several months, thus offering an advantage over recombinant proteins. 29 Prior studies from our lab have used traditionally fabricated demineralized bone matrix, collagen sponge, and ceramic composites as scaffolds to deliver transduced cells to critical-sized bone defects.…”
Section: Discussionmentioning
confidence: 99%
“…BMP‐7 is currently used in experimental studies to increase bone formation . It has been reported that BMPs induce heterotopic ossification and therefore BMP‐7 is one of the best reagents for establishing a positive control …”
Section: Introductionmentioning
confidence: 99%
“…Elucidation of novel strategies to promote reparative osteogenesis is critical and may potentially benefit large numbers of patients. Recombinant bone morphogenetic protein (BMP) 2, BMP 7, and teriparatide have been developed for clinical use as therapeutics that target inherent bone anabolic pathways, but each has disadvantages that have limited their widespread use …”
mentioning
confidence: 99%
“…Recombinant bone morphogenetic protein (BMP) 2, BMP 7, and teriparatide have been developed for clinical use as therapeutics that target inherent bone anabolic pathways, but each has disadvantages that have limited their widespread use. [4][5][6] The hedgehog (Hh) signaling pathway is critical to developmental osteogenesis 7,8 and bone homeostasis. 9 Hh ligands activate signaling through one pathway consisting of two transmembrane receptors: Patched1 (Ptch1) and Smoothened (Smo).…”
mentioning
confidence: 99%